SWITZERLAND-HEALTH-EBOLA-VACCINES

The University Hospital of Lausanne (CHUV) is pictured on October 28, 2014 in Lausanne, western Switzerland. Ebola vaccine trials are set to start in Switzerland this week after receiving the green light from the country's authorities. Swiss regulators announced they would allow trials of an experimental vaccine made by Britain's GlaxoSmithKine, and tests on some 120 individuals were set to get under way at the CHUV hospital in Lausanne this week. AFP PHOTO / FABRICE COFFRINI (Photo credit should read FABRICE COFFRINI/AFP via Getty Images)
The University Hospital of Lausanne (CHUV) is pictured on October 28, 2014 in Lausanne, western Switzerland. Ebola vaccine trials are set to start in Switzerland this week after receiving the green light from the country's authorities. Swiss regulators announced they would allow trials of an experimental vaccine made by Britain's GlaxoSmithKine, and tests on some 120 individuals were set to get under way at the CHUV hospital in Lausanne this week. AFP PHOTO / FABRICE COFFRINI (Photo credit should read FABRICE COFFRINI/AFP via Getty Images)
SWITZERLAND-HEALTH-EBOLA-VACCINES
PURCHASE A LICENCE
How can I use this image?
AED 1,850.00
AED

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Italy, Spain, Canada (not Quebec). Restricted editorial rights elsewhere, please call local office.
Credit:
FABRICE COFFRINI / Staff
Editorial #:
457982820
Collection:
AFP
Date created:
28 October, 2014
Upload date:
Licence type:
Rights-managed
Release info:
Not released. More information
Source:
AFP
Barcode:
AFP
Object name:
Par8014020
Max file size:
4490 x 2993 px (38.02 x 25.34 cm) - 300 dpi - 1 MB